Rudiger Kaspera, Director, Clinical Pharmacology | 5 March at 10:30am MST
First-in-Human studies of oligonucleotides: Strategies and considerations on study design, safety, pharmacokinetics, and dynamics towards an early proof of mechanism
Dr. Anne Behringer, Project Specialist | 25 March at 3:00 pm at the Dock 10 - Cross-Border Recruitment in Clinical Trials: A Perspective on Operational Reality
Poster presentation “Validity and reliability of a smartwatch single-lead ECG for monitoring QT interval prolongation: an interventional study with moxifloxacin”.
